Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract.
A regimen combining hepatic irradiation and intravenous dacarbazine and mitomycin C for treating colorectal adenocarcinoma with liver metastases offers no advance in the management of patients with this disease.